Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Aug;22(2):49-55.
doi: 10.4274/Mirt.69775. Epub 2013 Aug 1.

The value of somatostatin receptor imaging with In-111 Octreotide and/or Ga-68 DOTATATE in localizing Ectopic ACTH producing tumors

Zeynep Gözde Özkan  1 , Serkan Kuyumcu, Deniz Balköse, Berker Ozkan, Nihat Aksakal, Ebru Yılmaz, Yasemin Sanlı, Cüneyt Türkmen, Ferihan Aral, Işik Adalet
Affiliations

The value of somatostatin receptor imaging with In-111 Octreotide and/or Ga-68 DOTATATE in localizing Ectopic ACTH producing tumors

Zeynep Gözde Özkan et al. Mol Imaging Radionucl Ther. 2013 Aug.

Abstract

Objective: We aimed to evaluate the value of somatostatin receptor imaging (SRI) with In-111 octreotide and Ga-68 DOTATATE in localizing ectopic ACTH producing tumors.

Methods: Nineteen patients who had In-111 octreotide somatostatin receptor scintigraphy (SRS) and/or Ga-68 DOTATATE PET-CT to localize ectopic ACTH producing tumors between the years 2000 and 2012 were included retrospectively in our study. The results of SRI were compared with clinical onset, radiological findings and surgical data of the patients.

Results: Sixteen In-111 octreotide SRS and five Ga-68 DOTATATE PET-CT were performed in 19 patients. In eight out of 19 patients, ectopic ACTH secretion site could be detected. In five patients, SRS showed pathologic uptake. In four of these patients, surgery revealed pulmonary carcinoid tumors and in one patient pancreatic neuroendocrine tumor. In one patient, Ga-68 DOTATATE PET-CT revealed pathologic uptake in lung nodule which came out to be pulmonary carcinoid tumor. In another patient who had resection of metastases of atypical carcinoid tumor prior to scans, new metastatic foci were detected both with SRS and Ga-68 DOTATATE PET-CT imaging. In one patient, although SRS was negative, CT which was performed three years later showed a lung nodule diagnosed as pulmonary carcinoid tumor. In 11 patients, ectopic ACTH secretion site could not be detected. In 10 of those patients, scintigraphic and radiological imaging did not show any lesions and in one patient, Ga-68 DOTATATE PET-CT was false positive.

Conclusion: SRI has a complementary role with radiological imaging in localizing ectopic ACTH secretion sites. PET-CT imaging with Ga-68 peptide conjugates is a promising new modality for this indication.

Conflict of interest: None declared.

Keywords: Cushing syndrome; ectopic ACTH Syndrome; gallium radioisotopes; indium-111-octreotide; positron-emission tomography/computed tomography; scintigraphy; somatostatin receptor.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Summary of patient outcomesSRI: Somatostatin receptor imagingPt: patient
Figure 2
Figure 2. Planar images of In-111 octreotide SRS of 4 patients are shown: Pulmonary carcinoid tumors (A-C) and pancreatic neuroendocrine tumor (D) Please provide a better copy of Figure 2 C).
Figure 3
Figure 3. Planar and SPECT images of In-111 octreotide SRS of a patient with pulmonary carcinoid tumor. Although the planar image is negative (A), in sagittal (B), coronal (C) and axial (D) SPECT images the lesion can be seen
Figure 4
Figure 4. The centrally located pulmonary nodule in right lung lower lobe cannot be detected easily in CT image, but there is high Ga-68 DOTATATE uptake in PET image. The nodule can be easily detected in PET-CT fusion image.
Figure 5
Figure 5. The moderate Ga-68 DOTATATE uptake in the left adrenal lesion led to false positive interpretation of the image as the site of ectopic ACTH secretion, but the pathology revealed adrenal adenoma without ACTH staining.
See this image and copyright information in PMC

References

    1. Guyton AC, Hall JE. The textbook of medical physiology. Philadelphia: W.B. Saunders Company; 2000. The adrenocortical hormones; pp. 869–883.
    1. Tabarin A, Valli N, Chanson P, Bachelot Y, Rohmer V, Bex-Bachellerie V, Catargi B, Roger P, Laurent F. Usefulness of somatostation receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab. 1999;84:1193–1202. - PubMed
    1. Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA, Nieman LK. Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health. J Clin Endocrinol Metab. 2005;90:4955–4462. - PubMed
    1. Hernandez I, Espinosa-de-los-Monteros AL, Mendoza V, Cheng S, Molina M, Sosa E, Mercado M. Ectopic ACTH-secreting syndrome: a single center experience report with a high prevalence of occult tumor. Archives of Medical Research. 2006;37:976–980. - PubMed
    1. De Herder WW, Krenning EP, Malchoff CD, Hofland LJ, Reubi JC, Kwekkeboom DJ, Oei HY, Pols HAP, Bruining HA, Nobels FRE, Lamberts SWJ. Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing’s syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion. The American Journal of Medicine. 1994;96:305–312. - PubMed

LinkOut - more resources